Back to search

Article

The Global Compatibility Index (GCI): A Variance-Weighted Pharmacogenomic Scoring System Demonstrates Near-Perfect Cross-Mode Consistency (ICC = 0.994) and Improves Warfarin Dose Prediction Over the CPIC Algorithm in 5,475 Patients Across Four Continents, with Multi-Drug Validation Across 10 Independent Datasets

2026-05-12

Abstract excerpt

<title>Abstract</title> <p> <bold>Background.</bold> Adverse drug reactions (ADRs) account for 10–15% of all hospital admissions globally, with the majority attributable to variants in pharmacogenomically actionable genes. Current decision tools require genomic sequencing infrastructure unavailable in over 80% of the world's healthcare settings, creating a profound global equity gap in personalised prescribing....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2b630f4-c947-5c08-971e-48b28e910050
DOI
10.21203/rs.3.rs-9454760/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Global Compatibility Index (GCI): A Variance-Weighted Pharmacogenomic Scoring System Demonstrates Near-Perfect Cross-Mode Consistency (ICC = 0.994) and Improves Warfarin Dose Prediction Over the CPIC Algorithm in 5,475 Patients Across Four Continents, with Multi-Drug Validation Across 10 Independent DatasetsDOI 10.21203/rs.3.rs-9454760/v1
Select a neighboring publication to make it the new centre.